Table 2.
Clinical characteristics of 20 patients who underwent conversion surgery.
| Case | CEA (U/mL, Before) |
CEA (U/mL, After) |
CA19-9 (U/mL, Before) |
CA19-9 (U/mL, After) |
Tumor Size (mm, Before) | Tumor Size (mm, After) | Treatment Effect (RECIST) | Operative Method | Operative Time (min) | Bleeding Volume (mL) | Hospital Stay (Day) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2.4 | 2 | 25.9 | 9.9 | 27 | 13 | PR | SSPPD | 678 | 295 | 32 |
| 2 | 2.6 | 3.3 | 55.9 | 39 | 33 | 13 | PR | DP | 403 | 160 | 22 |
| 3 | 8 | 10.3 | 2789 | 24.9 | 32 | 23 | PR | DP | 373 | 260 | 50 |
| 4 | 1.1 | 5.1 | 81.4 | 34 | 50 | 50 | SD | DP | 438 | 1150 | 9 |
| 5 | 2.9 | 3.1 | 5103 | 19.9 | 23 | 12 | PR | SSPPD + PVR | 509 | 1250 | 11 |
| 6 | 9.4 | 4.4 | 92 | 10.9 | 29 | 13 | PR | SSPPD | 575 | 1220 | 23 |
| 7 | 6.4 | 2.4 | 253.5 | 49.6 | 24 | 9 | PR | SSPPD + PVR | 738 | 3010 | 16 |
| 8 | 2 | 2.7 | 9.2 | 11.4 | 42 | 10 | PR | SSPPD | 464 | 1030 | 10 |
| 9 | 1.5 | 1.6 | 1559 | 11.2 | 41 | 9 | PR | SSPPD + PVR | 574 | 1665 | 13 |
| 10 | 2.3 | 2.2 | 67.4 | 9 | 21 | 10 | PR | DP | 408 | 1075 | 11 |
| 11 | 3.4 | 3 | 20.6 | 7.4 | 30 | 16 | PR | SSPPD + PVR | 643 | 1390 | 9 |
| 12 | 2.5 | 3.2 | 1985 | 48.2 | 24 | 12 | SD | SSPPD + HPR | 841 | 2340 | 11 |
| 13 | 3.8 | 4.2 | 270 | 38.1 | 29 | 8 | PR | SSPPD | 729 | 2470 | 16 |
| 14 | 4.6 | 8 | 1515 | 16.4 | 41 | 34 | PR | SSPPD + PVR | 919 | 3600 | 47 |
| 15 | 5.1 | 3 | 1846 | 13.3 | 35 | 0 | CR | DP | 391 | 240 | 23 |
| 16 | 3.4 | 3.4 | 5.2 | 10.4 | 21 | 19 | SD | DP | 352 | 90 | 8 |
| 17 | 8 | 8.4 | 0.6 | 0.6 | 18 | 13 | SD | SSPPD | 623 | 1040 | 13 |
| 18 | 3 | 4.6 | 1047 | 10.7 | 32 | 11 | PR | SSPPD | 550 | 1020 | 8 |
| 19 | 1.8 | 2.1 | 516 | 17.8 | 30 | 9 | PD | TP + PVR + HPR | 613 | 460 | 14 |
| 20 | 2.9 | 9.5 | 330 | 99 | 24 | 25 | SD | SSPPD + PVR | 641 | 1695 | 13 |
UR-LA, unresectable locally advanced cancer; UR-M, unresectable cancer with metastasis; before, before initial therapy; after, after various therapy; PR, partial response; SD, stable disease; PR, partial response; SSPPD, substomach preserving pancretoduodenectomy; DP, distal pancreatectomy; PVR, portal vein resection; HPR, hepatic partial resection; TP, total pancreatectomy.